Anti-Fas (CD95) mAb (Monoclonal Antibody)
Fas Monoclonal Antibody.
Specifications:
Description
Monoclonal Antibody of 100 µl targeting Fas for FCM, WB.
| Target: | Fas |
|---|---|
| Product Type: | Antibody |
| Size: | 100 µl |
| Application: | FCM, WB |
| Research Area / Disease: | Apoptosis |
| Conjugate: | Unlabeled |
| Antibody Type: | Monoclonal |
| Clone Number: | CH-11 |
| Formulation: | 0.5 mg/mL in PBS/50% glycerol, pH 7.2 |
| Isotype: | IgM |
| Immunogen: | FS-7 Human diploid fibroblasts |
| Host Species: | Mouse |
| Species Reactivity: | Human |
| Source: | This antibody was purified from ascites fluid using affinity chromatography. This hybridoma (clone CH-11) was established by fusion of mouse myeloma cell NS-1 with Balb/c mouse splenocyte immunized with the human diploid fibroblast FS-7 cell lin E. |
| Reactivity: | This antibody induces apoptosis in human cell lines expressing Fas antigen |
| Gene ID Human: | |
| Gene ID Mouse: | |
| Storage Temperature: | -20°C |
| Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
Citations
- Murthy A et al. A Crohn’s disease variant in Atg16l1 enhances its degradation by caspase 3. Nature 506, 456-62 (2014),
- Zanin-Zhorov A et al. Fibronectin-associated Fas ligand rapidly induces opposing and time-dependent effects on the activation and apoptosis of T cells. J Immunol. 171, 5882-9 (2003)
- Yamaji, T., et al., J. Biol. Chem. 285, 35505-35518 (2010)
- Arokium, H., et al., J. Virol. 83, 11283-11297 (2009)
- Pallasch, C. P., et al., Blood 112, 4213-4219 (2008)
- Conus, S., et al., J. Exp. Med. 205, 685-698 (2008)
- Okamoto, K., et al., Genes Cells 11, 177-191 (2006)
- Ohgushi, M., et al., Mol. Cell. Biol. 25, 10017-10028 (2005)
- Kotone-Miyahara, Y., et al., J. Leukoc. Biol. 76, 1047-1056 (2004)
- Lee, K-K., et al., J. Biol. Chem. 276, 19276-19285 (2001)
- Ichikawa, K., et al., Int. Immunol. 12, 555-562 (2000)
- Tsukumo, S. I., et al., Genes Cells 4, 541-549 (1999)
- Yamashita, K., et al., Blood 93, 674-685 (1999)
- Ito, N., et al., Cell 66, 233-243 (1991)
- Kobayashi, N., et al., PNAS 87, 9620-9624 (1990)
- Yonehara, S., et al., J. Exp. Med. 169, 1747-1756 (1989)
- Kozako T et al. Novel small molecule SIRT2 inhibitors induce cell death in leukemic cell lines. BMC Cancer. 18, 791 (2018)
- Jing ZT et al. Hepatitis B Virus Surface Antigen Enhances the Sensitivity of Hepatocytes to Fas-Mediated Apoptosis via Suppression of AKT Phosphorylation. J Immunol. 201, 2303-2314 (2018)
